文摘
Purpose: To determine the proportion of adults with type 2 diabetes, who developed secondary failure to oral medications that had immune-mediated diabetes (IMD). Subjects and methods: One hundred and eight subjects who failed to oral therapy were screened for autoantibodies (ICA, IAA, IA-2A, and GADA65) and HLA DR/DQ markers of IMD. Results: Mean age was 49 years and mean body mass index (BMI) was 31.5 kg/m2; 21.3 % were non-Hispanic White (NHW), 32.3 % Latin American (LA), and 43.2 % African American (AA). Fourteen percent had one or more autoantibodies [Ab(+)]: five NHW, three LA, and seven AA. Ab(+) patients were younger (P